Newswire (Published: Tuesday, April 25, 2017, Received: Thursday, April 20, 2017, 7:02:43 PM CDT)

Word Count: 412

Research Conducted at Kanazawa University Has Provided New Information about Prostate Cancer (Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice)

By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Prostate Cancer are discussed in a new report. According to news reporting originating from Ishikawa, Japan, by NewsRx correspondents, research stated, "Availability of novel hormonal therapies as well as docetaxel and cabazitaxel treatment for metastatic castration-resistant prostate cancer (CRPC) has changed the outlook for this group of patients with improvements in progression-free survival and overall survival. Physicians often diagnose the progression of prostate cancer using serum prostate-specific antigen (PSA)."

Our news editors obtained a quote from the research from Kanazawa University, "However, serum PSA is not always correlated with the clinical status in CRPC. To evaluate the PSA dynamics with greater precision, understanding of the control of PSA and of the mechanisms of development of CRPC is needed. Moreover, it is necessary to use new hormonal therapies with an appropriate timing to optimally improve the prognosis and the QOL of the patients."

According to the news editors, the research concluded: "In the present review, we ascertain the PSA dynamics and the mechanisms of the development of CRPC to assist in optimal utilization of the new treatments for mCRPC."

For more information on this research see: Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice. Asian Journal of Andrology, 2017;19(2):143-148. Asian Journal of Andrology can be contacted at: Medknow Publications & Media Pvt Ltd, B-9, Kanara Business Centre, Off Link Rd, Ghaktopar-E, Mumbai, 400075, India. (Nature Publishing Group - www.nature.com/; Asian Journal of Andrology - www.nature.com/aja/)

The news editors report that additional information may be obtained by contacting A. Mizokami, Kanazawa University, Grad Sch Med Sci, Dept. of Integrat Canc Therapy & Urol, Kanazawa, Ishikawa 9208640, Japan. Additional authors for this research include K. Izumi, H. Konaka, Y. Kitagawa, Y. Kadono, K. Narimoto, T. Nohara, A.K. Bahl and M. Namiki (see also Oncology - Prostate Cancer).

Keywords for this news article include: Ishikawa, Japan, Asia, Prostate-Specific Antigen, Cancer, Article Review, Enzymes and Coenzymes, Prostatic Neoplasms, Peptide Hydrolases, Serine Proteases, Prostate Cancer, Endopeptidases, Kallikreins, Oncology, Kanazawa University.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

Kanazawa University

Places

Eastern Asia
Southern Asia
India
Japan
Asia
Mumbai

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Health Sciences
            Medical Research